Immix Biopharma (Nasdaq: IMMX) Employee Directory

Biotechnology ResearchUnited States11-50 Employees

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases. Our lead cell therapy is FDA IND cleared next generation CAR-T NXC-201, currently being evaluated in our ongoing Phase 1b/2 NEXICART-1 (NCT04720313) clinical trial, initiated in February 2021. NXC-201 has the potential to be the world’s first “Single-Day CRS” CAR-T (CRS median onset day 1, median duration 1 day), enabling the potential for a faster return home for patients and supporting ongoing expansion into autoimmune indications. NXC-201 has been awarded Orphan Drug Designation (ODD) by the FDA in both AL Amyloidosis and multiple myeloma, and ODD by the European Commission (EMA) in AL Amyloidosis. Learn more at www.immixbio.com and www.BeProactiveInAL.com.

Find Immix Biopharma (Nasdaq: IMMX) employees' phone numbers or email addresses

Immix Biopharma (Nasdaq: IMMX) Global Highlights

Location
Employees

North America
23

Minus sign iconPlus sign icon
  • United States Of America
    22
  • Canada
    1

South America
6

Minus sign iconPlus sign icon
  • Brazil
    6

Europe
1

Minus sign iconPlus sign icon
  • Luxembourg
    1

Immix Biopharma (Nasdaq: IMMX)'s Leadership

  • Stylized image of a person
    S. S.
    Co-Founder
    Phone icon
  • Stylized image of a person
    G. R.
    Acting Chief Medical Officer And Head Of Clinical Development
    Phone icon
  • Stylized image of a person
    V. T.
    Scientific Co-Founder
    Phone icon
  • Stylized image of a person
    B. L.
    Executive Vice President General Counsel
    Phone icon
  • Stylized image of a person
    F. E.
    Clinical Trial Project Manager
    Phone icon
  • Stylized image of a person
    M. F.
    Lead Clinical Data Manager
    Phone icon
  • Stylized image of a person
    P. M.
    Clinical Trial Manager
    Phone icon
  • Stylized image of a person
    N. O.
    Manager
    Phone icon

Contact profiles from Immix Biopharma (Nasdaq: IMMX)

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    G. R.
    Acting Chief Medical Officer And Head Of Clinical Development
    Phone icon
    Aug 26, 2024
  • Stylized image of a person
    S. S.
    Co-Founder
    Phone icon
    Jun 27, 2025
  • Stylized image of a person
    V. T.
    Scientific Co-Founder
    Phone icon
    Oct 22, 2024
  • Stylized image of a person
    B. L.
    Executive Vice President General Counsel
    Phone icon
    UNITED STATES
    Jul 29, 2024
  • Stylized image of a person
    F. E.
    Clinical Trial Project Manager
    Phone icon
    BrazilSão Paulo
    Nov 07, 2025
  • Stylized image of a person
    M. F.
    Lead Clinical Data Manager
    Phone icon
    BrazilPiauí
    Nov 07, 2025
  • Stylized image of a person
    P. M.
    Clinical Trial Manager
    Phone icon
    Luxembourg
    Nov 07, 2025
  • Stylized image of a person
    N. O.
    Manager
    Phone icon
    Oct 18, 2024
  • Stylized image of a person
    H. S.
    Corporate Strategy Senior Associate
    Phone icon
    United StatesNew York
    Nov 07, 2025
  • Stylized image of a person
    T. M.
    Clinical Research Associate
    Phone icon
    BrazilSão Paulo
    Nov 07, 2025

Frequently Asked Questions

What is Immix Biopharma (Nasdaq: IMMX) known for?

Minus sign iconPlus sign icon
Immix Biopharma (Nasdaq: IMMX) was founded in 2012 operates in the Biotechnology Research industry. The company's main headquarters is located in Los Angeles, Los Angeles, CA 90064, US. Explore Immix Biopharma (Nasdaq: IMMX)'s company overview page for more information.

What is Immix Biopharma (Nasdaq: IMMX)'s most common email format?

Minus sign iconPlus sign icon
Immix Biopharma (Nasdaq: IMMX) employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immix Biopharma (Nasdaq: IMMX) email formats with LeadIQ.

How many employees does Immix Biopharma (Nasdaq: IMMX) have currently?

Minus sign iconPlus sign icon
Immix Biopharma (Nasdaq: IMMX) has approximately 25 employees as of October 2025. These team members are located across 3 continents, including North AmericaSouth AmericaEurope.

Who are Immix Biopharma (Nasdaq: IMMX)'s key employees and leadership?

Minus sign iconPlus sign icon

As of October 2025, Immix Biopharma (Nasdaq: IMMX)'s key employees include:

  • Co-Founder: S. S.
  • Acting Chief Medical Officer And Head Of Clinical Development: G. R.
  • Scientific Co-Founder: V. T.
  • Executive Vice President General Counsel: B. L.
  • Clinical Trial Project Manager: F. E.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.